Huntington National Bank Amphastar Pharmaceuticals, Inc. Transaction History
Huntington National Bank
- $13.8 Billion
- Q4 2024
A detailed history of Huntington National Bank transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Huntington National Bank holds 1,340 shares of AMPH stock, worth $42,638. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,340
Previous 979
36.87%
Holding current value
$42,638
Previous $47,000
4.26%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
36.9MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$189 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$86.4 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$58.6 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$51.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.53MShares$48.7 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.56B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...